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Abstract
Introduction: The largest cohort of critically ill patients evaluating intragastric and small intestinal delivery of
nutrients was recently reported. This systematic review included recent data to compare the effects of small bowel
and intragastric delivery of enteral nutrients in adult critically ill patients.
Methods: This is a systematic review of all randomised controlled studies published between 1990 and March
2013 that reported the effects of the route of enteral feeding in the critically ill on clinically important outcomes.
Results: Data from 15 level-2 studies were included. Small bowel feeding was associated with a reduced risk of
pneumonia (Relative Risk, RR, small intestinal vs. intragastric: 0.75 (95% confidence interval 0.60 to 0.93); P = 0.01; I2
= 11%). The point estimate was similar when only studies using microbiological data were included. Duration of
ventilation (weighted mean difference: -0.36 days (-2.02 to 1.30); P = 0.65; I2 = 42%), length of ICU stay (WMD: 0.49
days, (-1.36 to 2.33); P = 0.60; I2 = 81%) and mortality (RR 1.01 (0.83 to 1.24); P = 0.92; I2 = 0%) were unaffected by
the route of feeding. While data were limited, and there was substantial statistical heterogeneity, there was
significantly improved nutrient intake via the small intestinal route (% goal rate received: 11% (5 to 16%); P =
0.0004; I2 = 88%).
Conclusions: Use of small intestinal feeding may improve nutritional intake and reduce the incidence of ICU-
acquired pneumonia. In unselected critically ill patients other clinically important outcomes were unaffected by the
site of the feeding tube.
Introduction
In the critically ill, nutritional therapy is a component of
standard care. Delivery into the gastrointestinal tract is
the preferred route of nutrient administration, via a tube
into either the stomach or small intestine [1]. However,
whether these feeding tubes should be preferentially
placed into the stomach or small intestine remains con-
tentious. Several clinical practice guidelines have recom-
mended that enteral nutrition should be commenced
using an intragastric tube [1,2], whereas other guidelines
advise that when small bowel feeding is feasible that this
route is preferable [3].
The advantages of commencing with intragastric feeding
include that naso- or oro-gastric tubes are relatively easy
to insert, so that once a decision is made to feed, delivery
of nutrient can promptly commence. However, disadvan-
tages of the intragastric approach include delayed gastric
emptying, which occurs frequently in the critically ill [4,5],
and predisposes to inadequate nutrient administration.
Indeed, observational studies, in which most patients
receive intragastric feeding, have shown that the propor-
tion of calories and protein delivered to critically ill
patients are about 50 to 70% of targeted calorie and
protein loads [6-8].
Small intestinal feeding tubes are more difficult to insert,
often requiring specific expertise and equipment. Their
potential advantages include bypassing the stomach, which
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should theoretically ‘guarantee’ delivery of nutrients, as the
major gastrointestinal motility disorders in the critically ill
appear to occur in the antral-pyloro region of the stomach
[9]. Not only does increasing administration of nutrients
have the potential to reduce mortality and length of stay,
particularly in those patients at risk of critical illness
malnutrition and its consequences [10], but delivery of
nutrients into the small intestine has been reported to
reduce the incidence of hospital-acquired pneumonia,
possibly because episodes of gastro-oesophageal regurgita-
tion occur less frequently [11,12]. Intuitively, a reduction
in pneumonia should shorten intensive care unit
(ICU) and hospital length of stay and may reduce
mortality [13].
Systematic reviews and meta-analysis have been pub-
lished that evaluated small bowel and gastric feeding in
the critically ill [14-17]. An update incorporating impor-
tant recent studies [18-20] was published by Jiyong and
colleagues [17]. However, a limitation of the latter review
is that the authors included a study in which patients
received care on the general hospital ward rather than a
critical care environment. In addition, Jiyong and collea-
gues included studies of both adult and paediatric subjects.
Finally, data from the ENTERIC study were not included,
and we believe that this study is the pivotal study in the
area [21]. For these reasons we sought to update previous
reviews to determine whether small bowel, when
compared to intragastric delivery of nutrition, is associated
with improved outcomes in the critically ill.
The objectives of this study were to determine the
effects of small bowel and gastric tube delivery of liquid
nutrients on hospital-acquired pneumonia, duration of
mechanical ventilation, length of ICU and hospital stay,
mortality and nutritional intake in adult critically ill
patients.
Methods
The meta-analysis was performed in line with the
recommendations from the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA)
statement [22].
Study identification
We conducted a systematic review of the published litera-
ture to identify all relevant randomised clinical trials.
Using text word or MeSH headings containing: “rando-
mized"; “blind"; “clinical trial"; “nutrition"; “enteral"; “small
bowel"; “gastric"; “nasojejunal"; “nasoduodenal"; and “naso-
gastric” computerised searches for relevant articles on
MEDLINE, EMBASE, BIIOSIS, CINAHL electronic
databases Cochrane Controlled Trials Register from 1990
to March 2013 were performed. Reference lists of review
articles and original studies were hand searched and rele-
vant articles extracted.
Study eligibility criteria
All primary studies were retrieved and reviewed. Primary
studies were eligible for inclusion if they: (1) studied adult
patients with critical illness; (2) compared small bowel
(delivered into the jejunum or duodenum) to gastric deliv-
ery; (3) included clinically important outcomes, such as
mortality, infectious complications (including hospital-
acquired pneumonia), length of stay or major nutritional
endpoints; and (4) were randomised clinical trials (RCTs).
We defined patients with critical illness as those who
were cared for in a critical care environment. Utilizing a
scoring system that has been previously reported [23],
RCTs were rated for methodological quality. Using pre-
viously piloted forms [23], two reviewers independently,
and in duplicate, then abstracted data from these studies.
Agreement was reached by consensus. We attempted to
contact the authors of included studies and requested
further information not contained in published articles.
Data synthesis
The primary outcome was the incidence of ICU-
acquired pneumonia. Secondary outcomes were duration
of mechanical ventilation, duration of ICU stay, duration
of hospital stay, mortality, and nutritional intake. We
used definitions of ICU-acquired pneumonia as defined
by the original study investigators.
To quantify nutritional intake we included only studies
that reported the mean (SD) percentage of calories or
volume delivered when compared to the patients’ energy
expenditure or prescribed volume as estimated by weight-
based or complex calculation. Data from all studies were
combined to estimate the common risk ratio (RR) and
associated 95% confidence intervals (CI) for mortality and
hospital-acquired pneumonia. In the meta-analysis, we
used maximum likelihood methods of combining risk
ratios across all trials and examined the data for evidence
of heterogeneity within groups. The Mantel-Haenszel
method was used to test the significance of treatment
effect. We used a random effects model to estimate the
overall relative risk. Heterogeneity was determined using
the Chi squared test and interclass correlation I2. We also
analysed the effect of small bowel delivery on duration of
mechanical ventilation, ICU stay and hospital stay; the
weighted mean difference (WMD) was used to describe
the standardised difference between mean duration of stay
from small bowel and intragastric delivery, respectively.
P-values < 0.05 were considered significant.
Subgroup and sensitivity analyses
There were substantial limitations when interpreting data
from two of the included studies. Taylor and colleagues
reported the effect of ‘enhanced’ enteral nutrition, that
ideally was administered via a small intestinal feeding tube
[24]. However, only 34% of the patients actually achieved
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feeding via the small bowel, which is markedly inferior to
rates of successful small intestinal tube placement reported
by other groups [25]. Minard and colleagues compared
patients who received early immune-enhanced enteral
nutrition via the small bowel to those receiving delayed
immune-enhanced enteral nutrition via the stomach [26].
Accordingly, when indicated, meta-analyses of outcome
data were performed with, and without, these two studies.
It should also be recognised that the diagnosis of ICU-
acquired pneumonia can be subjective. For this reason,
when evaluating the effect of small intestinal feeding on
the incidence of pneumonia we also report the subgroup
of studies that used microbiological data in association
with clinical data [27].
Results
The literature search resulted in 22 RCTs. After review-
ing these studies, four were excluded because they were
systematic reviews [14-17], one had < 50% of enrolled
patients admitted to an ICU [28], one did not report
clinical outcomes [11] and one [29] was an analysis of
data already included.
Studies
Results from these 15 level-2 RCTs were aggregated. None
of the studies were able to blind treating health care provi-
ders to the route of delivery once patients were rando-
mised, and only three studies included patients from more
than one ICU (Kortbeek, n = 2; Montejo, n = 11; Davies,
2012, n = 17). Only two groups reported registration of
their study [18,21]. The characteristics of the studies are
summarised in Table 1.
Placement of small intestinal feeding catheters
Various techniques were used to insert small intestinal
tubes (Table 1).
Success - and time to successful placement - of small
intestinal feeding tubes were not reported in all studies.
When reported (n = 11), success rates varied between 34
and 100%, with the median time to placement ranging
from 5 hours to 1.5 days (Table 1). Repeated testing to
confirm that the feeding tube remained in either the
stomach or small intestine throughout the patient’s admis-
sion was not reported in any study.
Standardisation in the intragastrically-fed group
While the ‘control’ group in all studies was, at least
initially, intragastric delivery, the use of gastrokinetic
drugs was inconsistently reported (Table 1).
Outcomes
Pneumonia
Twelve studies reported the incidence of ICU-acquired
pneumonia. The reported incidence of pneumonia ranged
from 9% to 46% of patients studied. Pneumonia was diag-
nosed according to a variety of techniques (Table 1), with
six studies incorporating microbiological and clinical data
[20,21,30-33], four studies used clinical signs and radiolo-
gical changes [18,19,34,35] and two studies did not
describe the technique used to make the diagnosis of
pneumonia [24,36]. In only four studies were the investiga-
tors blinded to treatment allocation when making the
diagnosis of pneumonia [19,21,30,31].
Small bowel feeding was associated with a reduced risk
of ICU-acquired pneumonia when compared to gastric
(relative risk (RR): small intestine vs. intragastric: 0.75
(0.60 to 0.93) P = 0.01; test for heterogeneity I2 = 11%;
Figure 1A). The point estimate was unaffected when the
studies by Taylor and Minard were removed (RR: 0.75
(0.56 to 1.00); P = 0.05; I2 = 21%). When analysing only
studies that included microbiological diagnosis, these
results remained similar (RR: 0.72 (0.55 to 0.93); P = 0.01;
I2 = 0%; Figure 1B).
Length of stay
Nine studies reported on ICU length of stay. Although
heterogeneity was present, length of stay appeared unaf-
fected regardless of whether small intestine or intragastric
tubes were used (weighted mean difference (WMD): 0.49
days (-1.36 to 2.33); P = 0.60; I2 = 81%; Figure 2A). Results
were unchanged when the study by Minard was excluded
(WMD: 0.04 days (-1.85 to 1.93); P = 0.97; I2 = 82%).
Hospital length of stay was also unaffected by small bowel
or intragastric administration of nutrients in the five
studies that reported this outcome (WMD: 0.56 days
(-3.60 to 4.73) P = 0.79; I2 = 24%; Figure 2B).
Duration of mechanical ventilation
Administration of nutrients directly into the small intes-
tine did not appear to influence duration of mechanical
ventilation (WMD: -0.36 (-2.02 to 1.30); P = 0.67; I2 =
42%; Figure 2C).
Mortality
Thirteen studies reported mortality data. Feeding via small
intestinal or intragastric tube did not affect mortality (RR:
1.01 (95% CI: 0.83 to 1.24); P = 0.92; I2 = 0%; Figure 3).
When the studies by Taylor and Minard were excluded,
data were unchanged (RR: 1.03 (0.84 to 1.27); P = 0.78; I2
= 0%).
Nutritional administration
Targets for nutritional delivery were based on formulae (n
= 7) or weight-based calculations (n = 4), with a few
studies either not, or inadequately, reporting how the
nutrition target was derived (n = 4) (Table 2). Only eight
studies reported the number of days of enteral nutrition
provided, which varied from less than 4 days to more than
11 days (Table 2).
Nine studies reported the amount of nutrients adminis-
tered to patients (calories ± protein). Of these studies, one
reported small intestinal feeding reduced the amount of
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Table 1 Characteristics of included studies
Study Total
subjects
Population (exclusion criteria are
listed when relevant)
(i) Intervention (small intestinal
or gastric group allowed
gastrokinetic drug/s and type)
(ii) Technique
(iii) Success of small bowel
placement in intervention group















38 Med/Surg Intensive Care Unit (ICU).
Patients anticipated to require ≥
days of nutrition



















Blinded New Chest x-ray (CXR)
changes + 3 of:
(i) sputum > 25 leukocytes < 10
epithelial and numerous bacteria;
(ii) sputum > 25 leukocytes < 10
epithelial and nosocomial
pathogen present;
(iii) Temperature > 101.4° F (38.6°C);
OR
(iv) White Cell Count > 10,000
(units)
Conceal: Uncertain
Intension To Treat (ITT):
No (analyzed according
to location of feeding
tube, rather than
intention to treat)
Blinding: No (Score 8)
2. Kortbeek
1999
80 Trauma Likely to require
mechanical ventilation (MV) > 48
hrs, and enroled < 72 from
admission, and Injury Severity




placement of a duodenal tube


















Blinded New CXR changes and 2
of: Temp > 38.5°C,;
(ii) WCC > 10,000 or < 3,000 (units);
(iii) purulent sputum; or
(iv) pathogenic bacteria cultured
from bronchoalveolar lavage (BAL)
Conceal: Yes ITT: Yes
Blinding: No (Score 11)
3. Taylor
1999
82 Traumatic Brain Injury (TBI), MV,
Glasgow Coma Scale (GCS) score >
3, and at least one reactive pupil
at some time during the first 24
hrs, as well as suitable for EN.
Exclusion criteria included
presence of any other organ failure














Diagnosis of pneumonia not
described
Conceal: Uncertain ITT:




44 Medical ICU, MV and EN ≥ days
Excluded patients with pancreatitis
and ileus
Small bowel versus Gastric
(gastrokinetic drugs allowed but
not reported)
(ii) blind placement with
metoclopramide
(iii) 21/21 (100%), but three
required fluoroscopy
(iv) < 10 minutes except if required











Not blinded New CXR changes and
and 2 of: Temp > 38.5°C;
(ii) WCC > 10,000 or




Yes Blinding: No (Score 9)
5. Minard
2000
27 Trauma GCS7 3 to 10 Excluded
patients with sepsis, kidney or
respiratory failure or requiring
vasoconstricting drugs














Not blinded CXR changes+
Purulent sputum+ Temp > 101°F+
WBC > 12,000 OR BAL > 100,000
CFUs
Conceal: Uncertain ITT:















Table 1 Characteristics of included studies (Continued)
6. Esparaza
2001
54 Medical ICU Inclusion criteria not
reported
Small bowel versus Gastric
(gastrokinetic drugs, erythromycin
or metoclopramide- allowed in
both groups. Reported as
administration per patient-fed days)
















Pneumonia not reported Conceal: Uncertain ITT:
Yes Blinding: No (Score 8)
7. Boivin
2001
80 Med/Surg ICU, MV in 98% Enteral
Nutrition (EN) ≥72 hrs Excluded:
pancreatitis, burns, severe head
injury
Small bowel versus Gastric (all
patients in both groups received
erythromycin)
(ii) blind placement with










Pneumonia not reported Conceal: Uncertain ITT:
No Blinding: No (Score 6)
8. Day 2001 25 Primary neurological diagnosis and
expected to receive EN for ≥ 3
days Patients were excluded who
had gastroparesis












Did not report how pneumonia
was diagnosed
Conceal: Uncertain ITT:
Yes Blinding: No (Score 5)
9. Davies
2002
73 Med/Surg ICU Expected to receive
EN ≥ days




(iv) time to placement not
reported. However, time to
commencing nutrition was delayed
in patients receiving small










Not blinded Clinical criteria, CXR
changes and microbiological data
Conceal: Uncertain ITT:




60 Medical ICU In need of enteral
nutrition excluded gastroparesis,
ileus and pancreatitis
Small bowel versus Gastric (no
comment gastrokinetic drugs)
(ii) blind placement, fluoroscopy as











Pneumonia not reported Conceal: Uncertain ITT:
Yes Blinding: No (Score 6)
11. Montejo
2002
101 Mixed ICUs EN > 5 days Patients
with gastroparesis allowed to enter
Small bowel versus Gastric (no
comment gastrokinetic drugs)
(ii) technique depending on local
expertise but included endoscopy
(n = 18), fluoroscopic guidance (n
= 12), blind technique (n = 15), or
by echography (n = 5).
(iii) 100%
(iv) time to small intestine 21.0 ±









Not blinded Diagnosed according
to criteria described by the Centre
for Disease Control
Conceal: Not sure ITT: Yes















Table 1 Characteristics of included studies (Continued)
12. Hsu
2009
121 Medical ICU EN > 3 days Excluded
intractable vomiting, severe
diarrhea, paralytic ileus and acute
pancreatitis
Small bowel Versus Gastric
(gastrokinetic drugs, such as
metoclopramide, erythromycin,
cisapride, allowed but not routinely
administered, administered n = 20/
62 (32%) gastric and 18/59 (31%)
small intestine
(ii) blind placement with













Blinded New CXR changes and one
of: T > 38 or < 36 with no other
recognized cause;
(ii) WCC > 12,000 or < 4,000; or
(iii) for adults ≥ 70 years and
altered mental status at least two
of new or change n purulent
sputum, new cough or tachypnea,
worsening gas exchange, and
bronchial breath sounds
Conceal: Yes ITT: Yes
Blinding: No (Score 9)
13. White
2009
108 Medical ICU MV > 24 hrs Small bowel versus Gastric
(gastrokinetic drugs,
metoclopramide and erythromycin,
administered for GRVs > 200 mL)














Not blinded New fever
Leukocytosis New CXR changes,
increased pulmonary secretions
and clinical pulmonary infection
score (CPIS) > 6
Conceal: Yes ITT: Yes




104 TBI on MV Expect EN required for
≥ 5 days Glasgow coma scale
(GCS) < 9, APACHE II between15-
30, sequential organ failure
assessment (SOFA) < 6
Small bowel Versus Gastric
(metoclopramide administered for
two consecutive GRV > 200 mL)














Not blinded CPIS > 6 required for
diagnosis. However, microbiological
data collected in all patients and
only one patient diagnosed with
pneumonia did not have a
pathogen isolated from the lower
respiratory tract
Conceal: No ITT: Yes
Blinding: No (Score 9)
15. Davies
2012
181 Mixed ICUs within 72 hrs of
admission Receiving MV Receiving
opiate drug via infusion Gastric
residual volume (GRV) > 150 ml or
> 500 ml over 12 hrs
Small bowel versus Gastric
(metoclopramide ≥ erythromycin
prn)
(ii) Self-migrating + erythromycin
(iii) 79/92 (87%)













Blinded Consensus panel of three
clinicians, pneumonia diagnosed by
at least two members based on
temp, WCC, sputum, P/F ratio,
microbiological results and CXR
Conceal: Yes ITT: Yes
Blinding: No (Score 11)















nutrients administered [18], four reported that it increased
nutrient delivery [19,20,30,34] and four reported that
energy and protein delivered was unaffected by route of
feeding [32,33,37] (Table 2).
Data from six studies that reported nutritional intake as
mean ± SD could be aggregated. In these studies there
was slight variation in the description of nutrient intake:
it was specified as percentage of daily caloric intake, per-
centage of estimated energy requirements received, and
‘mean efficacious volume of diet’. When these data were
grouped, small bowel feeding compared to gastric feeding
was associated with a significantly greater percentage of
nutritional intake (WMD 11% of intake/amount
prescribed [5,16]; P = 0.0004, I2 = 88%; Figure 4A). Data
from studies that reported the time to reach nutritional
goal rate were aggregated (n = 4), and there was no effect
detected (WMD -3.4 hours (-13.5 to 6.6); P = 0.51; I2 =
87%; Figure 4B).
Discussion
We conducted a systematic review and meta-analysis of
all RCTs of gastric vs. small bowel feeding in the ICU
setting, including the recently published ENTERIC study
[21]. The main observations are that delivery of nutri-
ents directly into the small intestine may be associated
with a reduction in the incidence of ICU-acquired pneu-
monia when compared to intragastric delivery, but
despite this, days of ventilation, ICU and hospital length
of stay and mortality appear unaffected. In addition,
while there were relatively few, and substantial heteroge-
neity between, studies that evaluated nutritional effi-
ciency, there was a signal that feeding into the small
intestine increased nutrient intake.
It is possible that our meta-analysis over-estimated
any reduction in pneumonia caused by small intestinal
feeding. In several studies the diagnosis of pneumonia
was made while investigators were aware of treatment
allocation. Moreover, nearly all studies were conducted
at a single ICU and the number of subjects was
relatively small. Biases, including publication and selec-
tion biases, are well known to occur in studies involving
fewer subjects, thereby affecting point estimates calcu-
lated in meta-analyses [38]. To limit bias we also ana-



















Heterogeneity: Tau² = 0.02; Chi² = 12.33, df = 11 (P = 0.34); I² = 11%





















































































Small Bowel Gastric Risk Ratio Risk Ratio
M-H, Random, 95% CI
0.1 0.2 0.5 1 2 5 10










Heterogeneity: Tau² = 0.00; Chi² = 3.18, df = 5 (P = 0.67); I² = 0%

















































Small Bowel Gastric Risk Ratio Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours Small bowel Favours Gastric
Figure 1 Small intestinal feeding and pneumonia. Twelve studies reported the: (A) incidence of pneumonia with (B) six studies incorporating
both microbiological data with clinical data when making the diagnosis.
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assessment. When this was performed, the interpreta-
tion remained similar supporting the original observa-
tion. Nevertheless, a reduction in pneumonia was not
apparent in the largest cohort studied (ENTERIC).
Given that discrepancies between meta-analyses and
the ‘truth’ occur frequently [39,40], circumspect inter-
pretation of these aggregate data related to the
incidence of pneumonia is recommended.
While we report a reduction in ICU-acquired pneumo-
nia, the number of days of ventilation, length of ICU and
hospital stay, as well as mortality, were unaffected by the
route of feeding. While the lack of effect on the latter out-
comes may reflect an inadequate sample size or, as
described, that our meta-analysis overestimated the effect
of route of feeding on the risk of pneumonia, there are
plausible mechanisms that may explain these seemingly
discrepant findings. In several of the studies artificial nutri-
tion was administered for only a short period and so-called
‘early-onset’ ventilator-associated pneumonia is often
caused by susceptible organisms and responds rapidly to
antibiotic therapy [41]. Accordingly, attributed outcomes,
such as length of ventilation and mortality, may actually
be unaffected by ‘early-onset’ hospital-acquired pneumo-
nia. Indeed, other factors, such as depth of sedation [42],
may be greater determinants of length of ventilation and
ICU stay than development of pneumonia.
There was a signal for increased nutritional intake
when using small intestinal feeding tubes. There was,
however, substantial statistical heterogeneity indicating
that this observation should be interpreted with caution.
The heterogeneity may reflect that placement of small
intestinal tube can be technically difficult, requiring
expertise and sophisticated methodologies [25]. Some-
what surprisingly, time-to-placement and placement
success was not consistently reported. We suggest that
the improvement in nutritional intake will only be gen-
eralisable to institutions that have the capacity to rapidly














Heterogeneity: Tau² = 4.93; Chi² = 41.62, df = 8 (P < 0.00001); I² = 81%
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Heterogeneity: Tau² = 5.40; Chi² = 5.25, df = 4 (P = 0.26); I² = 24%



























































Small Bowel Gastric Mean Difference Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10









Heterogeneity: Tau² = 1.57; Chi² = 8.67, df = 5 (P = 0.12); I² = 42%





























































Small Bowel Gastric Mean Difference Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Favours Small Bowel Favours Gastric
Figure 2 Small intestinal feeding and duration of ICU- and hospital admission and mechanical ventilation. (A) Nine studies reported the
duration of admission into the Intensive Care Unit (ICU), (B) five studies reported hospital admission length-of-stay, and (C) six reported length
of mechanical ventilation.
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Heterogeneity: Tau² = 0.00; Chi² = 6.11, df = 12 (P = 0.91); I² = 0%



























































































Small Bowel Gastric Risk Ratio Risk Ratio
M-H, Random, 95% CI
0.1 0.2 0.5 1 2 5 10
Favours small bowel Favours gastric
Figure 3 Small intestinal feeding and mortality. Thirteen studies reported mortality data.
Table 2 Nutritional outcomes reported
Study Days of artificial nutrition Determination of energy
requirements





Gastric 10.3 ± 10.0 d and Small








Control 11 days vs. Intervention 9
days (median).




Gastric 8 ± 1 days and Small











Small intestine 3.6 d; (mean)
Harris Benedict No, spread of data not reported
7. Boivin
2001
Not reported Weight-based No, data only in graphs and not described in text
8. Day 2001 Not reported Harris-Benedict Not included as data presented as percentage target per day.
However, increased nutrient delivery was observed with gastric




Small intestine 8.6 d; mean




Gastric 6.5 ± 4.4 d
Small intestine 5.3 ± 4.5 d
Mean ± SD
Not described No, but time to reach goal reported
11. Montejo
2002
Gastric 12 ± 10 d
Small intestine 11 ± 8 d
Mean ± SD
Not standardised but





Not reported Ireton-Jones equation Yes
13. White
2009
Gastric 3.92 (1.05 to 7.88) vs. small
bowel 3.63 (1.89 to 6.92) days;
median (IQR)





Not reported weight-based Yes
15. Davies
2012
EN for a median of 8 (interquartile
range 5 to 14) days.
Schofield Yes
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There were also inconsistencies between studies as to
reporting concurrent gastrokinetic drug administration.
This is likely to be important when trying to interpret the
nutritional data, as gastrokinetic drugs can have potent
effects on gastric emptying, but the response varies mark-
edly between drug classes and regimens [4,43,44]. It
should, therefore, be emphasised that data relating to
nutritional intake do not extend to a comparison between
small intestinal feeding and intragastric feeding with con-
current gastrokinetic drug administration.
While nutrient intake may have been ‘improved’, as dis-
cussed, mortality was unaffected. However, the optimal
amount of calories and protein that should be adminis-
tered to the critically ill is uncertain. Moreover, the bene-
fits of nutrient administration may vary according to a
number of factors specific to the individual patients.
Those likely to benefit more from artificial nutrition com-
pared to other ICU patients are those with a body mass
index at either extreme [6], increased NUTRIC score [45],
and anticipated prolonged length of stay in the ICU [10].
It should be emphasised that in some studies the period of
nutrition required was relatively brief [18]. Hence, the
power to detect any benefit from improved nutritional
efficiency is markedly diminished [45]. It should also be
noted that administration of more nutrient might have
effects that are important to patients, but are not mea-
sured using data such as length of stay and mortality. Rice
and colleagues reported that patients who received fewer
calories were less likely to return to independent living on
discharge [46]. Unfortunately, only one study reported
longer-term function (neurological outcomes in this case)
[24] and none measured muscle strength after ICU
discharge. These functional outcomes may be very
important to patients, and future studies of nutritional
interventions would benefit from measuring such
outcomes.
A further consideration is that the delivery of nutrients
into the small intestine does not guarantee absorption,
and it is absorption, rather than delivery of nutrients,
which will improve patient outcomes, as undigested nutri-
ents entering into the large intestine will lead to gas
formation and abdominal distension, as well as diarrhoea
[47]. Whether nutrients are administered proximal or
distal to the pylorus does not, however, appear to affect
absorption [48].
Although our search strategy was relatively compre-
hensive, and our methodology robust, there are several
limitations to our findings. Statistical heterogeneity was
modest and clinical heterogeneity was substantial. Some
studies attempted to identify a cohort that was likely to
have delayed gastric emptying [21], whereas others eval-
uated all patients requiring enteral nutrition at the
beginning of their ICU stay [18]. There are no studies
that include only patients with persistent feed-intoler-
ance and/or those at the greatest risk of ICU-acquired
pneumonia. This is important because while delayed
gastric emptying occurs frequently in the critically ill
[4,5], the prevalence is probably no greater than 30% of
all ICU patients that receive enteral nutrition. We
suggest that patients with relatively ‘normal’ gastric
emptying and oesophago-gastric motility are unlikely to
benefit from small intestinal feeding. For this reason, we
recommend against extrapolating this systematic review
to patients with documented enteral feed-intolerance (as
a marker of delayed gastric emptying) [49], particularly
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use, and/or those at the greatest risk of ICU-acquired
pneumonia - as these groups of patients may well bene-
fit from small intestinal feeding.
Future studies should therefore target patients who
develop feed-intolerance while receiving gastrokinetic
drugs. In particular, targeting patients who are most
likely to benefit from augmented nutritional delivery
and who will require nutritional support for a substan-
tial period of time will be a priority. In addition, these
studies would also benefit from using a technique that
affords rapidly and repeatedly successful placement of
small intestinal feeding tubes as well as measuring
longer-term functional outcomes.
Conclusions
Small bowel feeding may be associated with a reduction
in ICU-acquired pneumonia and increases in nutrient
delivery, but days of ventilation, ICU and hospital stay,
and mortality were unaffected. Until further data are
available, decisions as to whether to preferentially feed
patients into the small intestine will need to be at an
institutional level, incorporating the feasibility, safety
and delays in obtaining access, while identifying patients
most likely to benefit from this route of feeding.
Key messages
• In the critically ill, small intestinal feeding when
compared to intragastric may reduce the incidence
of ICU-acquired pneumonia.
• In the critically ill, small intestinal feeding when
compared to intragastric may increase nutritional
intake.
• The route of enteral nutrient administration (intra-
gastric or small intestinal) does not appear to be a
major determinant of mortality or length of stay in
unselected critically ill patients.
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